X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes

[1] Challis GB(1990)The spontaneous regression of cancer. A review of cases from 1900 to 1987 Acta Oncol 29 545-50

[2] Stam HJ(2009)Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance Nature 461 282-6

[3] Elliott MR(1992)Identification and distribution of the costimulatory receptor CD28 in the mouse J Immunol 149 380-8

[4] Chekeni FB(2007)Interferons at age 50: past, current and future impact on biomedicine Nat Rev Drug Discov 6 975-90

[5] Trampont PC(2006)Enzyme-catalysed assembly of DNA hydrogel Nat Mater 5 797-801

[6] Lazarowski ER(2004)Immunotherapeutic uses of CpG oligodeoxynucleotides Nat Rev Immunol 4 249-58

[7] Kadl A(2008)Toll-like receptor 9 (TLR9) agonists in the treatment of cancer Oncogene 27 161-7

[8] Walk SF(2008)Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients Cancer Invest 26 448-55

[9] Gross JA(2005)Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides J Immunol 175 3569-76

[10] Callas E(2008)Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation Immunology 124 247-55

[1] Challis GB(1990)The spontaneous regression of cancer. A review of cases from 1900 to 1987 Acta Oncol 29 545-50

[2] Stam HJ(2009)Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance Nature 461 282-6

[3] Elliott MR(1992)Identification and distribution of the costimulatory receptor CD28 in the mouse J Immunol 149 380-8

[4] Chekeni FB(2007)Interferons at age 50: past, current and future impact on biomedicine Nat Rev Drug Discov 6 975-90

[5] Trampont PC(2006)Enzyme-catalysed assembly of DNA hydrogel Nat Mater 5 797-801

[6] Lazarowski ER(2004)Immunotherapeutic uses of CpG oligodeoxynucleotides Nat Rev Immunol 4 249-58

[7] Kadl A(2008)Toll-like receptor 9 (TLR9) agonists in the treatment of cancer Oncogene 27 161-7

[8] Walk SF(2008)Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients Cancer Invest 26 448-55

[9] Gross JA(2005)Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides J Immunol 175 3569-76

[10] Callas E(2008)Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation Immunology 124 247-55